EUCTR2006-001198-18-IE进行中（未招募）不适用
Improving Tolerability of Statins - ITS-SGH
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •a. Individuals for whom intake of statin (ATORVASTATIN) is necessary as therapeutic intervention
- •b. Age 18 – 80 years old
- •c. Previous history of muscular related adverse reactions excluding rhabdomyolysis
- •d. Females: Post-menopausal, otherwise female using effective barrier contraception or is surgically sterilised
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •a. Previous history of rhabdomyolysis/angioedema associated with statin therapy
- •b. Hepatic and renal failure
- •c. Females who are pregnant or are planning pregnancy or are breastfeeding
- •d. Alcohol abuse
- •e. Patients who are enrolled in another clinical trial or who have been enrolled in a clinical trial in the 12 weeks preceding the study
- •f. Patients on acid lowering drugs (H2 antagonistis/proton pump inhibitor) or an antacids
研究者
相似试验
进行中（未招募）
1 期
Optimizing therapy with n=1-studies: negating the 'nocebo' effect in statin-intoleranceCTIS2023-507489-20-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)249
终止
3 期
atural products to lower cholesterolstatin intoleranceCardiovascular - Other cardiovascular diseaseshyperlipidemiacardiovascular diseaseACTRN12618000660280Curtin University49
已完成
不适用
Statins for Digital Ulcers and Raynaud's Phenomenon in systemic sclerosisSystemic sclerosisISRCTN26319635niversity of Alexandria (Egypt)80
进行中（未招募）
不适用
Evaluation of Statin Therapy- Safety, Effect and Toxicity Mechanisms.Frequency of side effects in patients treated with HMG CoA reductase inhibitors.MedDRA version: 8.1Level: LLTClassification code 10058108Term: DyslipidaemiaEUCTR2006-004686-34-SEKarolinska University Hospital
Unknown
4 期
The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) TrialCardiovascular Risk FactorCardiovascular DiseasesAdverse EffectNCT03889314Minneapolis Heart Institute Foundation25